title: Intra-vaginal use of misoprostol for induction of labour in intrauterine death.
abstract: This prospective study was done in the Department of Obstetric & Gynaecology in Mymensingh Medical College & Hospital during the period of February 2006 to January 2007, to assess the efficacy of vaginal misoprostol for induction of labour in intrauterine foetal death cases and to detect any intrapartum or postpartum complications. For this study, 50 cases of IUD were selected among admitted patients who were diagnosed by detailed history, clinical examination and by USG. Fifty microgram of misoprostol was given per vaginally, which was repeated 4 hours interval upto effective uterine contraction to a maximum six doses. All the informations were recorded in a predesigned structured data collection sheet and data had been interpreted through appropriate statistical analysis. In this study, 46% patients were within 18-25 years of age and gestational age between 28-37 weeks was 80%. Regarding causes of IUD, commonest was idiopathic (52%), next was gestational hypertension, pre-eclampsia, impending eclampsia (28%). Most of the patients (80%) had no history of antenatal checkup and belongs to below average socioeconomic status. Most case (64%) had less Bishop's score (<3) & all cases had unfavourable cervix, score <6. Vaginal delivery was 98% and 2% needed caesarean section. Mean induction delivery interval was 11.8 hours. Induction delivery interval was within 6-23 hours and 66% cases needed 2-3 doses of vaginal misoprostol. Complications were found in a minor group of patients. Nausea, vomiting, occurred in 12% of cases. Others were fever (2%), shivering (6%), PPH (4%), chorioamniotitis (2%) etc. Vaginal misoprostol for cervical ripening and labour induction is very effective and shorten the time of induction delivery interval. On the other hand, misoprostol is quite cheap, easy to administer, well tolerability and less side effects.
authors.affiliation: Upazila Health Complex, Trishal, Mymensingh, Bangladesh.
authors.forename: S
authors.initials: S
authors.lastname: Easmin
authors.forename: K
authors.initials: K
authors.lastname: Nahar
authors.forename: M K
authors.initials: MK
authors.lastname: Jahan
authors.forename: R
authors.initials: R
authors.lastname: Rahim
authors.forename: T A
authors.initials: TA
authors.lastname: Nila
authors.forename: K
authors.initials: K
authors.lastname: Nigar
authors.forename: N A
authors.initials: NA
authors.lastname: Khan
mesh_terms: D000282:Administration, Intravaginal; D000293:Adolescent; D000328:Adult; D005260:Female; D005313:Fetal Death / Q000628:therapy*; D006801:Humans; D007751:Labor, Induced / Q000379:methods*; D016595:Misoprostol / Q000008:administration & dosage*; D011247:Pregnancy; D011446:Prospective Studies
chemical_list: D016595:Misoprostol